Access to Genetic Testing in Underserved Patients With Cancer

NARecruitingINTERVENTIONAL
Enrollment

800

Participants

Timeline

Start Date

October 24, 2023

Primary Completion Date

October 24, 2027

Study Completion Date

October 24, 2028

Conditions
Breast CarcinomaMale Breast CarcinomaMalignant Solid NeoplasmMetastatic Prostate CarcinomaOvarian CarcinomaPancreatic Exocrine NeoplasmStage IVB Prostate Cancer American Joint Committee on Cancer v8Triple-Negative Breast Carcinoma
Interventions
OTHER

Best Practice

Receive provider-based genetic counseling

OTHER

Educational Intervention

Receive genetics education

OTHER

Electronic Health Record Review

Ancillary studies

OTHER

Genetic Counseling

Receive provider-based genetic counseling

OTHER

Interview

Ancillary studies

OTHER

Survey Administration

Ancillary studies

Trial Locations (2)

14642

RECRUITING

University of Rochester, Rochester

90033

RECRUITING

USC / Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Northeastern University

OTHER

collaborator

Dana-Farber Cancer Institute

OTHER

lead

University of Southern California

OTHER